AnthonyPGulatiMD

PubMed

• 22 citations
  A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;Cancer Cell. 2020 Dec 14
• 1185 citations
  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
  Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera, Sanjay Shete, Chih-Yuan Hsu, Aakash Desai, Gilberto Lopes, Petros G...> ;Lancet. 2020 Jun 20
• 45 citations
  Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.
  Eric Liu, Scott Paulson, Anthony Gulati, Jon Freudman, William W. Grosh, Sheldon Kafer, Prasanna Wickremesinghe, Ronald R. Salem, Lisa Bodei> ;The Oncologist. 2019 Jun 1
• 1 citations
  Time for a change and to adopt a novel molecular genomic approach in NETs.
  Lisa Bodei, Eric Liu, Scott Paulson, Anthony Gulati, Jon Freudman, William W. Grosh, Sheldon Kafer, Prasanna Wickremesinghe, Ronald R. Salem> ;Nature Reviews. Clinical Oncology. 2019 Apr 1
• 68 citations
  High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a...
  Brad E. Zacharia, Anthony Paul Gulati, Jeffrey N. Bruce, Arthur S. Carminucci, Sharon L. Wardlaw, Markus D. Siegelin, Helen Remotti, Angela Lignelli, Robert L. Fine> ;Neurosurgery. 2014 Apr 1
• 180 citations
  Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
  Robert L. Fine, Anthony Paul Gulati, Benjamin A. Krantz, Rebecca A. Moss, Stephen M. Schreibman, Dawn Tsushima, Kelley B. Mowatt, Richard D. Dinnen, Yuehua Mao, Peter ...> ;Cancer Chemotherapy and Pharmacology. 2013 Jan 31
• 8 citations
  Treatment of Multiple Endocrine Neoplasia 1/2 Tumors: Case Report and Review of the Literature
  Anthony Paul Gulati, Benjamin A. Krantz, Rebecca A. Moss, Wendy N Moyal, Dawn Tsushima, Kelley B. Mowatt, Stephen M. Schreibman, Robert L. Fine> ;Oncology. 2013 Jan 1
• 15 citations
  The clinical management of BRCA1 and BRCA2 mutation carriers
  Anthony P. Gulati, Susan M. Domchek> ;Current Oncology Reports. 2008 Feb 7
• 20 citations
  Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-κB, but not C-Jun N-terminal kinase and activated pro...
  Anthony P. Gulati, Yang Ming Yang, David H. Harter, Asok Mukhopadhyay, Bharat A. Aggarwal, Deborah L. Benzil, John Whysner, Anthony P. Albino, Raj Murali, Meena Jhanwa...> ;Molecular Carcinogenesis. 2006 Jan 1
• Join now to see all